Radiation Therapy Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Breast Cancer

Clinical trial NCT03359954 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03359954
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Estrogen Receptor Positive HER2/Neu Negative Invasive Breast Carcinoma Progesterone Receptor Positive

Start date: 2017-11-16
Primary completion: 2027-10-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.